FF-10101-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FF-10101-01, covering 2024-12-24 to 2024-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]